Stay updated on Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange Detected- The page revision tag was updated from v3.4.2 to v3.4.3. This is a minor metadata update and does not affect the page's content or functionality.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded Revision: v3.4.2 to the page. The funding-status notices from earlier versions (lapse in government funding and related operating-status details) have been removed.SummaryDifference0.4%

- Check65 days agoChange DetectedAdded a government funding notice banner about potential delays and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check72 days agoChange DetectedAdded a glossary toggle and updated metadata related to QC status and policy (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed or changed the previous QC label and revision reference (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check86 days agoChange DetectedRevision: v3.3.4 replaced v3.3.3 on the page. This appears to be a minor update with no changes to study details or user-facing functionality.SummaryDifference0.1%

Stay in the know with updates to Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.